Impact of long-term anti-TNF-alpha treatment on insulin resistance in patients with rheumatoid arthritis.
Seriolo
B
B
Paolino
S
S
Ferrone
C
C
Cutolo
M
M
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000503:physiopathology*; D006801:Humans; D000069285:Infliximab; D007333:Insulin Resistance / Q000502:physiology*; D011446:Prospective Studies
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab